CHESTPulmonary Vascular Disease

Pulmonary Vascular Disease

In brief: what’s new and notable in pulmonary vascular disease

Explore new and notable updates in pulmonary vascular disease, including research into sex differences in outcomes of thrombectomy in patients with pulmonary embolism, the effects of exercise on alveolar dead space on patients with heart failure, and drug-drug interactions in pulmonary arterial hypertension (PAH) treatment. Review treatment recommendations for PAH shared during CHEST 2022, highlights from recent guideline updates from the European Society of Cardiology and European Respiratory Society, and available simulation sessions in 2023.

On this page

RESOURCES

Education Spotlight

Navigating PAH

NEWS

Updates to PAH treatment guidelines

EDUCATION

Simulation 2023

Advertisement

Pulmonary vascular disease resources for patients and clinicians

Clinician education resources to explore

EDUCATION SPOTLIGHT
EDUCATION SPOTLIGHT

Pulmonary hypertension: Sessions from CHEST 2022

Take a deep dive into pulmonary hypertension diagnosis, management, and treatment with this curated list of relevant session recordings from CHEST 2022.

Management of Acute Pulmonary Embolism: Pro/Con Debates
E-LEARNING

Management of Acute Pulmonary Embolism: Pro/Con Debates

Some aspects of treatment for acute pulmonary embolism remain controversial. Review pros and cons of each in this course.

Nurse in ICU
GUIDELINES

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report

Review the latest update to CHEST’s guidelines for antithrombotic therapy and the prevention of thrombosis.


Patient education resources to share

A new diagnosis of PAH can be confusing and frightening for patients. Help them better understand their disease and what to expect from treatment with resources covering the symptoms, therapies, and risk factors for PAH and busting common myths surrounding living with this disease. Plus, a comprehensive patient guide offers an in-depth look into every aspect of PAH, from diagnosis to treatment and long-term management.

Advertisement

 

Pulmonary vascular disease news and notes

Follow the latest pulmonary vascular disease news

CHEST DAILY NEWS

Real-world scenarios show complexity of initial and ongoing PAH treatment decisions
More than a dozen treatment options are available for PAH. Review data on available therapies and management recommendations.

PULMONARY VASCULAR & CARDIOVASCULAR NETWORK

Key messages from the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Read highlights from recent guideline updates from the European Society of Cardiology (ESC) and European Respiratory Society (ERS).

CHEST PHYSICIAN®

Restoration of RV function in PAH: Is it the holy grail to improve mortality and long-term outcomes?
Read this review of recent research into the efficacy of techniques for improving mean pulmonary arterial pressure (mPAP) and the effects mPAP has on patient outcomes.

CHEST PHYSICIAN®

Emerging role of cardiopulmonary obstetric critical care
Review strategies to decrease maternal morbidity and mortality rates among patients with preexisting or newly discovered heart and lung diseases.

DATA TRENDS

Pulmonology Data Trends 2022
Get quick-hit overviews of the latest data on a wide variety of important topics in pulmonary medicine with infographics developed by leaders in the field.

PODCAST

Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19
Hear the authors of a recent article published in the journal CHEST debate the potential benefits and risks of administering therapeutic heparin to patients with COVID-19.

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »